US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims https://t.co/m6G8qfZ7BP https://t.co/m6G8qfZ7BP— Reuters (@Reuters) April 18, 2026
US judge rejects Bayer bid to block Johnson & Johnson prostate cancer drug claims
@Reuters·X: @Reuters··1 min read
X
Continue reading on X: @Reuters
This article was sourced from X: @Reuters's RSS feed. Visit the original for the complete story.